Frequently asked questions in the medical management of high-grade glioma: A short guide with practical answers

2008-09-01

Annals of Oncology , Volume 19 - Issue SUPPL. 7

Additional Metadata
Keywords	alkylating agent, antibiotic agent, anticonvulsive agent, bevacizumab, carmustine, cetuximab, cilengitide, corticosteroid, cotrimoxazole, cytotoxic agent, dacarbazine, dapsone, drug derivative, enzastaurin, everolimus, hydroxychloroquine, irinotecan, lenalidomide, lomustine, methotrexate, methylated DNA protein cysteine methyltransferase, pentamidine, pentamidine isethionate, procarbazine, temozolomide, temsirolimus, thiotepa, tipifarnib, unindexed drug, valproic acid, vandetanib, vincristine
Persistent URL	doi.org/10.1093/annonc/mdn474, hdl.handle.net/1765/14689
Journal	Annals of Oncology
Note	Free full text at PubMed
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Stupp, R., Hottinger, A., van den Bent, M., Dietrich, P. Y.& Brandes, A. (2008). Frequently asked questions in the medical management of high-grade glioma: A short guide with practical answers. Annals of Oncology, 19(SUPPL. 7).https://doi.org/10.1093/annonc/mdn474

Publication